Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection

Molecular Therapy : the Journal of the American Society of Gene Therapy
Samuel G JacobsonWilliam W Hauswirth

Abstract

AAV2 delivery of the RPE65 gene to the retina of blind RPE65-deficient animals restores vision. This strategy is being considered for human trials in RPE65-associated Leber congenital amaurosis (LCA), but toxicity and dose efficacy have not been defined. We studied ocular delivery of AAV-2/2.RPE65 in RPE65-mutant dogs. There was no systemic toxicity. Ocular examinations showed mild or moderate inflammation that resolved over 3 months. Retinal histopathology indicated that traumatic lesions from the injection were common, but thinning within the injection region occurred only at the two highest vector doses. Biodistribution studies at 3 months postinjection showed no vector in optic nerve or visual centers in the brain and only isolated non-dose-related detection in other organs. We also performed biodistribution studies in normal rats at about 2 weeks and 2 months postinjection and vector was not widespread outside the injected eye. Dose-response results in RPE65-mutant dogs indicated that the highest 1.5-log unit range of vector doses proved efficacious. The efficacy and toxicity limits defined in this study lead to suggestions for the design of a subretinal AAV-2/2.RPE65 human trial of RPE65-associated LCA.

References

May 15, 1993·American Journal of Medical Genetics·S R LambertM Pembrey
Jun 15, 1999·Toxicologic Pathology·M A Serabian, A M Pilaro
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·J BennettS G Jacobson
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·M M LaVailW W Hauswirth
Jun 9, 2001·Veterinary Ophthalmology·K.N. Gelatt, E.O. MacKay
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·James W KijasGregory M Acland
May 17, 2002·Human Molecular Genetics·Frans P M CremersAnneke I den Hollander
Feb 25, 2003·Toxicologic Pathology·Robert L Hall, Nancy E Everds
Oct 25, 2003·Progress in Retinal and Eye Research·Enrico M Surace, Alberto Auricchio
Dec 24, 2003·The Veterinary Record·Franco Mutinelli
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nadine S DejnekaJean Bennett
Apr 27, 2004·Trends in Molecular Medicine·Markus N Preising, Steffen Heegaard
Jul 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anne K HennigMark S Sands
Sep 7, 2004·Expert Review of Molecular Diagnostics·David G Birch
Jan 8, 2005·BMJ : British Medical Journal·Jonathan Kimmelman
Jan 26, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nathalie ProvostFabienne Rolling
Feb 15, 2005·Progress in Retinal and Eye Research·Steven K FisherMark R Verardo
Apr 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Samuel G JacobsonJean Bennett
Jun 28, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Megan GriffeyMark S Sands
Oct 15, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ji-jing PangWilliam W Hauswirth
Oct 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gregory M AclandSamuel G Jacobson

❮ Previous
Next ❯

Citations

Jan 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Artur V CideciyanGustavo D Aguirre
Sep 13, 2007·Proceedings of the National Academy of Sciences of the United States of America·Samuel G JacobsonKrzysztof Palczewski
Oct 24, 2013·EMBO Molecular Medicine·Ivana TrapaniAlberto Auricchio
Jun 13, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tanya TolmachovaMiguel C Seabra
Jun 21, 2014·Visual Neuroscience·G Jane FarrarArpad Palfi
Jan 16, 2008·The Journal of Biological Chemistry·Marcin GolczakKrzysztof Palczewski
Sep 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Artur V CideciyanWilliam W Hauswirth
Dec 25, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Knut StiegerFabienne Rolling
Jan 6, 2009·Journal of the American Veterinary Medical Association·Marta G P CastelhanoRory J Todhunter
Dec 17, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Eleni A MarkakisD Eugene Redmond
Apr 10, 2010·Human Molecular Genetics·András M KomáromyGustavo D Aguirre
Aug 13, 2010·Gene Therapy·M J AnnearS M Petersen-Jones
Sep 3, 2010·The Journal of Clinical Investigation·Anneke I den HollanderFrans P M Cremers
Mar 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·David L SimonsSamuel M Wu
Jun 28, 2011·Postgraduate Medical Journal·Melissa M LiuChi-Chao Chan
Aug 25, 2011·European Journal of Human Genetics : EJHG·Marian M HumphriesPeter Humphries
Nov 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Li JiangWolfgang Baehr
Jan 25, 2013·Gene Therapy·V S LopesD S Williams
Jan 30, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shannon E BoyeWilliam W Hauswirth
May 2, 2012·Human Gene Therapy·Arpad PalfiG Jane Farrar
May 31, 2012·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Robert B HufnagelRobert A Sisk
Apr 18, 2009·Ophthalmic Genetics·Xue CaiMuna I Naash
Jan 17, 2007·Expert Opinion on Biological Therapy·Mariacarmela AlloccaAlberto Auricchio
Feb 9, 2011·Expert Opinion on Biological Therapy·Linda SteinShalesh Kaushal
Sep 22, 2012·Progress in Retinal and Eye Research·Daniel M LipinskiRobert E MacLaren
Apr 20, 2010·Progress in Retinal and Eye Research·Artur V Cideciyan
Jan 12, 2010·The Veterinary Journal·András M Komáromy
May 15, 2013·Clinical Genetics·K Branham, B M Yashar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.